Daniel J. Lippis, CVP, TAVR at Edwards Lifesciences Corp (EW), sold 2,290 shares at $83.99 ($191K) on 2026-05-01, disclosed to the SEC on 2026-05-04.
Scheduled sale ($191k) by CVP, TAVR under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $82.99 | 1,000 | $83K | 43.4% |
| 2 | $83.99 | 19 | $2K | 0.8% |
| 3 | $83.98 | 252 | $21K | 11.1% |
| 4 | $83.98 | 1,019 | $86K | 44.7% |
| Total | $83.55 avg | 2,290 | $191K | 100% |
| Filing → |
| EW | SELL | 2026-08-11 | $57K | — | Filing → |
| EW | SELL | 2026-07-10 | $57K | — | Filing → |
| EW | SELL | 2026-06-30 | $57K | — | Filing → |